These studies also showed that inhibition of the EGFR pathway reduced the expression of PD-L1, suggesting that the oncogenic EGFR pathway is the main mechanism regulating PD-L1 expression in EGFR-mutant lung cancer [18–20]. Here, EGFR is linked to lung cancer.